A rare genetic mutation found in patients with Alzheimer’s may provide further insight into the pathologic mechanisms that cause the disease.
Monthly Archives: October, 2020
Treatment-resistant breast cancer could be made vulnerable to immunotherapy by flipping a metabolic “switch,” according to a new Northwestern Medicine study.
A group of scientists combined medicinal chemistry and human stem cells to improve a medication treating a cardiac rhythm disorder, a strategy that could be applied broadly.
The COVID-19 contact tracing process, led by health departments across the state, and coordinated by the Illinois Department of Public Health, involves a team of dedicated team members tracking the spread of the disease.
A new study found that Black men with metastatic prostate cancer were more likely to have tumor mutations than white or Asian men, highlighting the significance genetic drivers have in increasing one’s risk for developing aggressive prostate cancer.
In collaboration with the Office of Diversity and Inclusion, student groups organized the medical school’s first Diversity and Inclusion Week, which explored the importance of diversity, inclusion and representation in medicine and society.
A first of its kind drug called vosoritide may increase bone growth in children with achondroplasia, the most common form of dwarfism, according to findings from a recent clinical trial.
A nationwide clinical trial has found that patients taking antibiotics for appendicitis reported the same quality of life measures as those who underwent surgery.
Northwestern investigators have developed a novel vaccine that utilizes a specialized group of B-cells to promote anti-tumor immunity against glioblastoma.